WHO-GMP Certified Commercial Pack · Product Code: AKP-037
Sucralfate 1000mg & Oxetacaine 20mg Oral Suspension (per 10ml)
Formulation Overview: Ulcer-coating sucralfate suspension reinforced with oxetacaine topical anaesthetic to insulate exposed nerve endings from gastric acid while shielding mucosal tissue regeneration. Formulated with Sucralfate IP 1000 mg + Oxetacaine BP 20 mg (per 10 ml) (1000 mg + 20 mg / 10 ml) in Oral Cytoprotective Suspension dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 200 ml Amber PET Bottle with Graduated Measuring Cup with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-037 |
|---|---|
| Therapeutic Sector | Gastroenterology & PPIs |
| Dosage Form | Oral Cytoprotective Suspension |
| Active Ingredient | Sucralfate IP 1000 mg + Oxetacaine BP 20 mg (per 10 ml) |
| Strength / Purity | 1000 mg + 20 mg / 10 ml |
| Clinical Indication | Painful gastric and duodenal ulcers, acute radiation/NSAID esophagitis, and burning epigastric distress |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 200 ml Amber PET Bottle with Graduated Measuring Cup |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; shake well before use; do not freeze |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |